A multiomic study describes, for the first time, the accumulation of genetic alterations that dictate the malignancy of a type of thyroid tumour, more prevalent in children and young adults.
Read moreUnderstanding the responsibilities involved in Drug Substance and Drug Product manufacturing is essential for making the right strategic decisions. Many biotech companies approaching clinical phases d...
Read moreBlocking specific cellular signaling pathways may be an effective approach to treating this type of cutaneous lymphoma. One of its characteristics is its high genetic and molecular heterogeneity, whic...
Read moreUsing CRISPR-Cas technology, they eliminate or resensitise multi-resistant strains of E. coli without affecting the gut microbiota
Read moreThe biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...
Read moreA study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants...
Read moreThe strategy developed by the IR Sant Pau team uses multivalent protein nanoconjugates capable of specifically recognizing cells that express CXCR4. These nanoparticles act as precision delivery vehic...
Read moreA study published today in Nature Communications reveals a new way of measuring that editing process, known as splicing, directly. It is the first time scientists have been able to get a clear view of...
Read moreThe team has unexpectedly discovered that cells from the brain immune system play a role in the sexual maturation process. The link between them is RANK, a protein involved in mammary gland developmen...
Read moreUnlike current drugs, which mainly remove beta-amyloid plaques that accumulate in the brain, this new experimental drug reprogrammes the neuronal epigenome by correcting alterations in gene expression...
Read more3PBIOVIAN and the Colombia INC has signed a contract to carry out the development of a biosimilar monoclonal antibody (mAb) for an oncology indication, marking the first biosimilar mAb to be developed...
Read moreLos dispositivos de DNA Genotek se han convertido en un estándar internacional: desde su capacidad para estabilizar el ADN a temperatura ambiente durante meses hasta su facilidad de uso y su rendimie...
Read more